Iron metabolism, free radicals, and oxidative injury

Biomedicine and Pharmacotherapy

Volumn 55, Issue 6, 2001, Pages 333-339

  Emerit, J ^a   Beaumont, C ^b   Trivin, F ^a  

^a SAINT JOSEPH HOSPITAL   (France)

^b INSERM   (France)

Author keywords

Deferroxamine; Free iron; Oxidative stress

Indexed keywords

ANTIOXIDANT; CYTOCHROME; DEFEROXAMINE; DNA; FREE RADICAL; HYDROGEN PEROXIDE; IRON CHELATE; SUPEROXIDE;

CYTOTOXICITY; ELECTRON TRANSPORT; HOMEOSTASIS; HUMAN; INFLAMMATORY DISEASE; IRON ABSORPTION; IRON METABOLISM; IRON OVERLOAD; IRON STORAGE; IRON TRANSPORT; METABOLIC REGULATION; MUTAGENIC ACTIVITY; OXIDATIVE STRESS; OXYGEN AFFINITY; OXYGEN TOXICITY; PHLEBOTOMY; PRIORITY JOURNAL; REVIEW;

EID: 0034949363     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(01)00068-3     Document Type: Review

References (45)

1. Sem. Iron free radicals, and oxidative injury
2. Superoxide-dependent formation of hydroxyl radical and lipid peroxidation in the presence of iron salt: Detection of catalytic iron and antioxidant activity in extracellular fluids
3. Interplay between ferritin metabolism, reactive oxygen species and nitric oxide
4. Fluorescence analysis of the labile iron pool in mammalian cells
5. Iron, oxygen radicals, and disease
6. Allyl alcohol induced hemolysis and its relation to iron release and lipid peroxidation
7. On the limited ability of super oxide to release iron from ferritin
8. Cellular iron processing and storage: The role of ferritin
9. The ferritins, molecular properties, iron storage function, and cellular regulation
10. Red cell cycle
11. Disorders of iron metabolism
12. Le récepteur de la transferrine: Rôle dans le métabolisme du fer et intérêt en biologie clinique
13. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter
14. Hephaestine, a ceruloplasmine homologue implicated in intestinal iron transport
15. Iron release from human monocytes after erythrophagocytosis in vitro
16. Pathways for the regulation of macrophge iron metabolism by the antiinflammaory cytokines 1l-4 and Il-13
17. Linkage of cell immunity to iron metabolism
18. Iron and the liver
19. Structure and dynamics of the iron responsive element RNA
20. Haptoglobin polymorphism, iron metabolism and mortality in HIV infection
21. Ferritin level in pediatric HIV-1 infection
22. Prevalence of high serum and red cell ferritin levels in HIV infected patients
23. Biological and clinical significance of haptoglobin polymorphism in humans
24. Serum ferritin, desferoxamine, and evolution of HIV infection in thalassemic patients
25. Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria
26. Bark, weeds, and iron chelators - Drugs for malaria
27. Role of iron in the natural history and clinical course of hepatitis C disease
28. Heterozygoty for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C
29. Hepatic iron overload inpatients with chronic viral hepatitis: Role of HFE gene mutations
30. Response to interferon is influenced by the iron content of the liver
31. Liver iron concentration and distribution in chronic hepatitis C before and after interferon treatment
32. A pilot randomized controlled trial of the effect of iron depletion on long term response to interferon therapy in patients with chronic hepatitis C
33. Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon
34. In situ detection of lipid peroxidation in chronic hepatitis C
35. Involvement of iron and iron catalyzed free radical production in ethanol metabolism and toxicity
36. Iron induced carcinogenesis: The role of redox regulation
37. Free radicals and the etiology of colon cancer
38. Iron and the sex difference in heart disease risk
39. Iron chelators
40. Iron metabolism in the erythrophagocytosing Kupfer cell
41. Paraquat toxicity is enhanced by iron and reduced deferoxamine in laboratory mice
42. Failure of deferoxamine to modify the toxicity of paraquat in rats
43. Iron removal therapy in porphyria cutanea tarda phlebotomy versus slow subcutaneous deferroxamine infusion
44. Phase II trial of Cu, Zn-SOD in the treatment of Crohn disease
45. Deferoxamine therapy in high-ferritine diabetes